Archive for the ‘genetics’ category: Page 426
Jan 26, 2018
El Sueño de Andrómeda — Bioquark Inc. — Regenerage
Posted by Ira S. Pastor in categories: aging, bioengineering, biological, cosmology, cryonics, DNA, futurism, genetics, health, life extension
Jan 25, 2018
Bioquark Inc. — Best Damn Podcast — Ira Pastor
Posted by Ira S. Pastor in categories: aging, bioengineering, business, cosmology, cryonics, DNA, futurism, genetics, health, life extension
Jan 25, 2018
Bioquark Inc. — Caring For Aging Parents Podcast — Ira Pastor
Posted by Ira S. Pastor in categories: aging, bioengineering, biotech/medical, business, cryonics, DNA, genetics, health, life extension
Jan 23, 2018
Bioquark Inc. — Bloomer Boomer — “Plus 50″ Good Life Movement — Ira Pastor
Posted by Ira S. Pastor in categories: aging, bioengineering, biotech/medical, cryonics, disruptive technology, futurism, genetics, health, science, transhumanism
Jan 23, 2018
Bioquark Inc. — Staying Alive UK Show — Ira S. Pastor
Posted by Ira S. Pastor in categories: aging, bioengineering, biotech/medical, business, disruptive technology, DNA, futurism, genetics, health, neuroscience
Jan 22, 2018
Bioquark Inc. — HVMN Enhancement Podcast — Ira Pastor
Posted by Ira S. Pastor in categories: aging, bioengineering, biotech/medical, disruptive technology, DNA, futurism, genetics, health, innovation, life extension
Jan 22, 2018
USA WEEKLY — Ira S. Pastor — CEO at Bioquark Inc.
Posted by Ira S. Pastor in categories: aging, bioengineering, biotech/medical, business, disruptive technology, DNA, futurism, genetics, science, transhumanism
HANGZHOU, China—In a hospital west of Shanghai, Wu Shixiu since March has been trying to treat cancer patients using a promising new gene-editing tool.
U.S. scientists helped devise the tool, known as Crispr-Cas9, which has captured global attention since a 2012 report said it can be used to edit DNA. Doctors haven’t been allowed to use it in human trials in America. That isn’t the case for Dr. Wu and others in China.
In a hospital west of Shanghai, Wu Shixiu since March has been trying to treat cancer patients using a promising new gene-editing tool.
